Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Accenture
Boehringer Ingelheim
Cipla
Harvard Business School
Healthtrust
Chubb
Farmers Insurance

Generated: January 20, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: Sandoz Inc

« Back to Dashboard

Sandoz Inc Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Sandoz Inc fosaprepitant dimeglumine 203939 150MG INJECTABLE;INJECTION
Sandoz Inc caspofungin acetate 200833 70MG/VIAL INJECTABLE; INJECTION
Sandoz Inc lisdexamfetamine dimesylate 202836 40MG CAPSULE;ORAL
Sandoz Inc sitagliptin; metformin hydrochloride 202388 50MG; 500MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Federal Trade Commission
Cerilliant
Medtronic
Cantor Fitzgerald
Covington
Baxter
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.